Driven by consistent research and development efforts and government initiatives aimed at making healthcare more accessible to everyone, France has grown to house one of the largest pharmaceutical markets in the world.
As of January 2025, the country’s annual medicine production was valued at over $46 billion, capturing 2.8 percent of the global market, a figure that’s expected to climb. Below are some of the pharmaceutical companies in France looking for new talent.
Pharmaceutical Companies in France
- Sanofi
- Cencora
- Inato
- Acino
- LFB
- Simulations Plus
- ARCHIMED
- Curium Pharma
- Alexion Pharmaceuticals
- AbbVie
Pharmaceutical Companies in France to Know
Acino delivers affordable healthcare to patients and professionals in high-growth regions through contract manufacturing and out-licensing. Founded in 1936 and headquartered in Zurich, the company has expanded its operations to 90 countries, including France.
Founded in 1996, Simulations Plus provides modeling and simulation software and consulting services to support every stage of drug discovery and development. Headquartered in the United States, the company licenses its technology to leading pharmaceutical, biotechnology and chemical companies worldwide.
AbbVie develops and commercializes drugs for chronic and complex health issues in immunology, oncology, neuroscience and other areas. The global company operates in five world regions and over 70 countries, including France.
Sanofi provides sustainable and socially responsible treatment options and vaccines for people with diabetes and other chronic illnesses. Headquartered in Paris and present in 100 countries worldwide, the company serves millions of people globally.
Paris-based Curium Pharma specializes in manufacturing radiopharmaceutical products for cancer treatment, focusing on neuroendocrine tumors and prostate cancer. According to the company, it aims to become a global leader in oncology-focused nuclear medicine by 2030.
France-based LFB specializes in developing and marketing plasma-derived medicines, with a strong focus on treating hemostasis disorders, as well as immunology and intensive care conditions. It is the leading provider of these medicines in France and is among Europe’s top companies in next-generation protein development.
Inato’s platform is designed to make clinical research accessible to all patients, regardless of location, by connecting research centers to trials worldwide. In early 2025, the company introduced an AI-powered patient prescreening tool to help research sites quickly and efficiently assess patient eligibility for clinical trials.
Founded in 1871, Cencora’s team of 46,000 employees distributes pharmaceuticals, over-the-counter products and home healthcare equipment, improving access to healthcare for both humans and animals. The company operates 12 offices worldwide, including locations in Gennevilliers and Marseille.
Alexion Pharmaceuticals, a subsidiary of AstraZeneca, specializes in developing treatments for rare diseases, offering medications like Koselugo, Soliri and Kanuma. With a workforce of over 3,000 employees, the company supports patients in more than 50 countries worldwide.
ARCHIMED is a healthcare-focused investment and consultancy firm that supports growth and innovation in biopharma, healthcare IT, medtech and other sectors. By managing a €8 billion portfolio, the firm helps companies expand their products and enhance patient care.
